Get all your news in one place.
100's of premium titles.
One app.
Start reading
The New Daily
The New Daily
John Elder

New antibiotic: Successful clinical trial for ‘superbug’ killer

Antibiotic-resistant bacteria, such as this strain of Staphylococcus, could be the world's biggest killer by 2050. Photo: Getty

An experimental antibiotic that targets antibiotic-resistant ‘superbugs’ has proved to be safe and well tolerated in a Phase 1 clinical trial.

The new drug, QPX9003, was developed by Monash University researchers – and offers some real hope to holding off a predicted ‘superbug’ catastrophe.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.